Crypto exchange veteran, investor, and entrepreneur Andrew Chae has become another addition to the Wisebitcoin decentralized exchange’s team. Following a recent announcement by colleague Sangwook Lee, he joins the company as a senior advisor as well. Both have seen potential in the cryptocurrency exchange to develop services for professional traders that are unparalleled in the industry.
Mr. Chae is the former CSO of Huobi Korea, a leading exchange in the Asian cryptocurrency markets, and Bluehelix Korea Co-CEO, a pioneering blockchain technology provider. Andrew Chae’s participation in Wisebitcoin is sure to bring key insights into building better tools and customer service, both of which are features that distinguish Wisebitcoin among its competitors. The new senior advisor is also known for founding the Korea-China Leaders Forum.
"I'm happy to join Wisebitcoin as an advisor and I'm excited to contribute in optimizing Wisebitcoin's ability to provide the public with a safe but easy exchange environment," said Mr. Chae.
Wisebitcoin recently launched special trading features such as the unique ability to place long and short positions with leverage of up to 100:1 for contract trading to over 15 million users and 280 merchants around the globe. The exchange also offers deep liquidity and around-the-clock customer service.
Wisebitcoin is a global decentralized exchange for professional traders with a multicultural team of over 50 specialists. The platform provides unparalleled services such as 24/7 live phone support, cloud infrastructure, an affiliate program, and deep liquidity. Other important features include a user-friendly interface, a mobile app, and an insurance fund for asset protection.
The above review statements are those of the sponsor (Source of content) and do not necessarily reflect the official policy, position or views of the content publisher. The content distribution company is therefore not responsible for the content and its authenticity and legal standing of the above subject matter. Each individual is required to exercise its content when making a purchase from the above offer. The information does not constitute advice or an offer to buy. Any purchase made from the above press release is made at your own risk. Editorial merit of this content is subject to news publisher and its downstream partners. Consult an expert advisor/health and professional advisor before any such purchase. Any purchase made from this link is subject to the final terms and conditions of the website's selling as mentioned in the above as source. The content publisher and its downstream distribution partners do not take any responsibility directly or indirectly. If you have any complaints or copyright issues related to this article, kindly contact the company this news is about.
DISCLAIMER of Liability. IN NO EVENT SHALL OUR PR COMPANY BE LIABLE OR RESPONSIBLE TO YOU OR ANY OTHER PERSON FOR ANY DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, OR EXEMPLARY DAMAGES OF ANY KIND, INCLUDING WITHOUT LIMITATION, LOST PROFITS OR LOST OPPORTUNITIES, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES IN ADVANCE AND REGARDLESS OF THE CAUSE OF ACTION UPON WHICH ANY SUCH CLAIM IS BASED, INCLUDING, WITHOUT LIMITATION, ANY CLAIM ARISING OUT OF OR IN CONNECTION WITH ANY OF THE CONTENT, INCLUDING, WITHOUT LIMITATION, AUDIO, PHOTOGRAPHS, AND VIDEOS, OR OF THE ACCURACY, RELIABILITY, OR LEGALITY OF ANY STATEMENT MADE IN OR OMITTED FROM ANY advertisement, sponsorship, endorsement, testimonial, opinion, or other product-related or service-related statement or review appearing in the Websites or in ANY post or article distributed via the Websites.
Release ID: 16960